Viewing Study NCT02060266


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-25 @ 8:16 PM
Study NCT ID: NCT02060266
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2014-02-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Healthy View
Keywords: